Malignant somatostatinoma: clinical features and metabolic studies.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1981-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM-52-5-886PMID 6112232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation and characterization of immunoreactive somatostatin from fish pancreatic islets.

  1980cited by this paper
• Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B-cell-selective somatostatin analog.

  1980cited by this paper
• Somatostatinoma syndrome. Biochemical, morphologic and clinical features.

  1979cited by this paper
• A Malignant Insulinoma Transformed into a Glucagonoma Syndrome

  1979cited by this paper
• Differential sensitivity to somatostatin of pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas.

  1979cited by this paper
• Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.

  1979cited by this paper
• Somatostatin and Pancreatic Polypeptide Secretion: Effects of Glucagon, Insulin, and Arginine

  1978cited by this paper
• Calcitonin secretion by a pancreatic somatostatinoma.

  1978cited by this paper
• "Somatostatinoma": follow-up studies.

  1977cited by this paper
• PANCREATIC SOMATOSTATINOMA: Clinical Features and Physiological Implications

  1977cited by this paper
• Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.

  1977cited by this paper
• "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas.

  1977cited by this paper
• Immunoreactive somatostatin in pancreatic islet-cell carcinoma accompanied by ectopic A.C.T.H. syndrome.

  1977cited by this paper
• Ketoacidosis in pancreatectomized man.

  1977cited by this paper
• Somatostatinoma": follow-up studies.

  1977cited by this paper
• Somatostatinoma.

  1977cited by this paper
• Studies on the mechanism of somatostatin action on insulin release. III. Effect of somatostatin on arginine induced release of insulin and glucagon in man and perfused rat pancreas.

  1976cited by this paper
• Radioimmunoassay of vasoactive intestinal peptide.

  1976cited by this paper
• Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

  1976cited by this paper
• Effect of Insulin on the Exaggerated Glucagon Response to Arginine Stimulation in Diabetes Mellitus

  1976cited by this paper
• Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

  1975cited by this paper
• Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion.

  1975cited by this paper
• Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.

  1975cited by this paper
• Hyperparathyroidism: Gastric Acid Secretion and Gastrin

  1972cited by this paper
• Immunoassay for human calcitonin. II. Clinical studies.

  1971cited by this paper
• Dysimmunoglobulinemia associated with hepatobiliary disorders.

  1970cited by this paper
• THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES

  1970cited by this paper
• Studies of pancreatic alpha cell function in normal and diabetic subjects.

  1970cited by this paper
• Pancreatic glucagon secretion in normal and diabetic subjects.

  1969cited by this paper
• Dysimmunoglobulinemia in the absence of clinical features of multiple myeloma and macroglobulinemia.

  1967cited by this paper
• Stimulation of insulin secretion by amino acids.

  1966cited by this paper
• COLORIMETRIC DETERMINATION OF FREE FATTY ACIDS IN BIOLOGICAL FLUIDS.

  1965cited by this paper
• Immunoassay of Human Growth Hormone in Plasma

  1963cited by this paper
• PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY‐RECOGNIZED AND RELATED SYNDROME, “Hγ‐2-CHAIN (FRANKLIN'S) DISEASE”

  1963cited by this paper
• Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats

  1963cited by this paper
• Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood.

  1962cited by this paper
• Enzymic determination of d(−)-β-hydroxybutyric acid and acetoacetic acid in blood

  1962cited by this paper

• Clinicopathological Data and Treatment Modalities for Pancreatic Somatostatinomas

  2020cites this paper
• New and emerging syndromes due to neuroendocrine tumors.

  2011cites this paper
• NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

  2010cites this paper
• Malignant somatostatinoma presenting with diabetic ketoacidosis and inhibitory syndrome: pathophysiologic considerations.

  2010cites this paper
• Duodenal somatostatinoma associated with diabetic ketoacidosis presumably caused by somatostatin-28 hypersecretion.

  2005cites this paper
• The diagnosis and medical management of advanced neuroendocrine tumors.

  2004cites this paper
• Metastatic psammomatous somatostatioma of the pancreas causing severe ketoacidotic diabetes cured by surgery

  1997influential citation
• The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

  1996cites this paper
• Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.

  1996cites this paper
• Von recklinghausen's disease associated with duodenal somatostatinoma: Contrast of duodenal versus pancreatic somatostatinomas

  1995cites this paper
• Diagnosis and Medical Management of Gastroenteropancreatic Tumours

  1993cites this paper
• Effect of hypersomatostatinemia on growth hormone secretion in cystic fibrosis patients with diabetes.

  1993cites this paper
• 10 APUDomas and diabetes mellitus

  1992cites this paper
• APUDomas and diabetes mellitus.

  1992cites this paper
• Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide.

  1991cites this paper
• Pancreatic somatostatinoma: A case report and review of the literature

  1990cites this paper
• A Case of Pancreatic Somatostatinoma Found Endoscopically with Metastasis to the Duodenal Periampulla

  1990cites this paper
• Anatomic distribution of pancreatic endocrine tumors.

  1990cites this paper
• Somatostatin and its analogues in the therapy of gastrointestinal disease.

  1989cites this paper
• Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.

  1988cites this paper
• Pancreatic somatostatinoma: presentation with recurrent episodes of severe hyperglycaemia and ketoacidosis.

  1988cites this paper
• Malignant pancreatic somatostatinoma in a patient with dermatitis herpetiformis and coeliac disease.

  1988cites this paper
• Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin.

  1988cites this paper
• Islet Cell Tumors and Diabetes Mellitus

  1988cites this paper
• Somatostatinomas, PPomas, neurotensinomas.

  1987cites this paper
• Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.

  1987cites this paper
• Ectopic pituitary and hypothalamic hormone syndromes.

  1987cites this paper
• [Somatostatin-producing endocrine pancreatic tumor in Recklinghausen's neurofibromatosis. Case report and literature review].

  1987cites this paper
• Somatostatinoma: A case report and review of the literature

  1987cites this paper
• MALIGNANT SOMATOSTATINOMA PRESENTING WITH DIABETIC KETOACIDOSIS

  1987cites this paper
• Comparative diagnostic value of the calcium-pentagastrin test versus the tolbutamide test in a patient with a somatostatinoma.

  1987cites this paper
• Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study.

  1986cites this paper
• Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E--a clinicopathological, biochemical, immunohistochemical, and ultrastructural study.

  1986cites this paper
• Somatostatin-producing tumors.

  1985cites this paper
• Gastroenteropancreatic endocrine tumors

  1985cites this paper
• An operative case of primary malignant somatostatinoma of the papilla of vater with neurofibromatosis.

  1985cites this paper
• Somatostatinoma--the most recently described pancreatic islet cell tumor.

  1985cites this paper
• Early somatostatinoma of the papilla of the duct of Santorini.

  1985cites this paper
• [Endocrine pancreatic tumor secreting somatostatin and somatocrinin].

  1985cites this paper
• Somatostatinoma of the cystic duct

  1984cites this paper
• Somatostatinoma syndrome accompanied by overproduction of pancreatic polypeptide.

  1984cites this paper
• The influence of somatostatin on gallbladder response to intraduodenal acid and autonomic nerve stimulation in the cat.

  1984cites this paper
• Somatostatin--physiological and pathophysiological aspects.

  1983cites this paper
• Psammomatous somatostatinomas of the duodenum

  1983cites this paper
• Somatostatinoma syndrome: does a clinical entity exist?

  1983cites this paper
• Ampullary somatostatinoma: psammomatous variant of gastrointestinal carcinoid tumor--an immunohistochemical and ultrastructural study. Report of a case and review of the literature.

  1983cites this paper
• Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.

  1983cites this paper
• Somatostatinoma syndrome の一例

  1983cites this paper
• Pancreatic somatostatinoma.

  1983cites this paper
• Functional pathology of pancreatic islets: immunocytochemical exploration.

  1983cites this paper
• Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects

  1983cites this paper
• Somatostatin biosynthesis by cerebral cortical cells in monolayer culture.

  1983cites this paper
• Somatostatin-like immunoactivity and biological activity is present in a human pheochromocytoma.

  1983cites this paper
• Somatostatin — A Regulatory Peptide of Clinical Importance

  1982cites this paper
• Glucagonoma tumors and syndrome.

  1981cites this paper